New research offers treatment advances for stomach and esophageal cancers
Stomach and esophageal cancers are diagnosed in more than 40,000 people each year in the U.S. Most of these cases aren’t detected until the cancers are advanced. Unfortunately, available treatment options are not as effective once a cancer becomes metastatic.
Most patients with metastatic stomach or esophageal cancer are treated with combination chemotherapy, but their outcomes can vary widely.
“We select combinations based...
How Therapeutics Discovery is developing targeted therapies for more cancer types
Discovering and developing new treatments for cancer is a difficult process with many obstacles. These challenges can slow the process of...